Ticagrelor With Aspirin Dual Antiplatelet Therapy Combined With Intravenous Thrombolysis for Ischemic Stroke

Clinical trial NCT06316570 · COMPLETED

Trial details

NCT number: NCT06316570
Sponsor: Beijing Tiantan Hospital
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Ischemic Stroke, Acute

Start date: 2024-04-03
Primary completion: 2025-12-31
Enrollment: 1382

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.